Skip to main content
Clinical Trials/JPRN-jRCTs071180072
JPRN-jRCTs071180072
Recruiting
Phase 4

Examination of enhanced endoscopic ultrasonography using perflubutane in patients with suspected pancreatobiliary tumor - PEUSstudy

ueki toshiharu0 sites600 target enrollmentMarch 20, 2019

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
pancreatobiliary disease
Sponsor
ueki toshiharu
Enrollment
600
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 20, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ueki toshiharu

Eligibility Criteria

Inclusion Criteria

  • Admitted patients with suspected pancreatobiliary tumor at departoment of gastroenterology in Fukuoka University Chikushi Hospital

Exclusion Criteria

  • Patients who fall under one or more of the following exclusion criteria are not included.
  • (1\) Patients with a history of hypersensitivity to the ingredients of this drug
  • (2\) Patients with are allergic to eggs or egg products
  • (3\) Patients with an arteriovenous (right and left) shunt in the heart and lungs
  • (4\) Patients with severe heart disease
  • (5\) patients with severe lung disease
  • (6\) Patients with the doctor in charge deems inappropriate for this study

Outcomes

Primary Outcomes

Not specified

Similar Trials